dbb-wp

dbb-wp
1 year

Duopharma Biotech brings Flavettes Glow to Indonesia

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
1 year

Duopharma Biotech optimistic on 2024 outlook with Q1FY2024 results

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
1 year

Duopharma Biotech forms R&D partnerships for new therapies

MoUs with Centre for Affordable Diagnostics & Therapeutics Limited and PAMOJA Therapeutics BV seek to repurpose anti-malarial drug artesunate for cancer therapy and other applications

dbb-wp
2 years

Duopharma Biotech partners Owen Mumford to distribute medical devices

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Duopharma Biotech ends FY2023 with a marginal increase in revenue

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Duopharma Biotech partners with Tourism Malaysia to boost immunity among travellers

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Duopharma Biotech brings IRORO range to Australia with Tepanouits

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Duopharma Biotech partners Renalworks to enhance dialysis services with innovative software

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Nationwide campaign promoting balanced nutrition among school children officially concludes

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.

dbb-wp
2 years

Duopharma Biotech sees revenue recovery in Q3 FY2023

Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) announced profit before tax of RM21.47 million in the second quarter of 2022, an increase of 6.3% from the previous corresponding quarter due to improved sales in the ethical classic segment and public health sector during the period.